Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure

Behavioural Pharmacology

Volumn 14, Issue 2, 2003, Pages 97-109

  Oliveto, Alison ^a   Sevarino, K ^b   McCance Katz, E ^b   Benios, T ^b   Poling, J ^b   Feingold, A ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

Clonidine; Drug discrimination; Human; Naloxone; Opioid dependence; Opioid withdrawal; Yohimbine

Indexed keywords

ACETYLMETHADOL; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABIS; CHLORPROMAZINE; CLONIDINE; DESIPRAMINE; DIAMORPHINE; DIAZEPAM; HALOPERIDOL; IMIPRAMINE; LYSERGIDE; METHADONE; MORPHINE; NALOXONE; NALTREXONE; NEUROLEPTIC AGENT; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; PENTOBARBITAL; PHENOTHIAZINE; PLACEBO; SEDATIVE AGENT; TRIAZOLAM; YOHIMBINE;

ADRENERGIC ACTIVITY; ADULT; ANXIETY DISORDER; ARTICLE; ATTENUATION; BLOOD PRESSURE; BODY TEMPERATURE; BREATHING RATE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HEART RATE; HUMAN; MALE; OPIATE ADDICTION; QUESTIONNAIRE; SELF REPORT; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; TRAINING; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WEIGHT GAIN; WITHDRAWAL SYNDROME;

EID: 0037367794     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200303000-00001     Document Type: Article

References (52)

1. Aghajanian GK (1978). Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186-188.
2. Aghajanian GK, Wang YY (1987). Common alpha-2 and opiate effector mechanisms in the locus coeruleus: Intracellular studies in brain slices. Neuropharmacology 26:789-800.
3. Ambrosio E, Iglesias V, Garcia-Lecumberri C, Orensanz L, Alguacil LF (1997). Effects of yohimbine on the development of morphine dependence in the rat: Lack of involvement of cortical beta-adrenoceptor modifications. Pharmacol Biochem Behav 56:487-491.
4. Ballard TM, McAllister KH (1999). Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice. Pharmacol Biochem Behav 62:285-290.
5. Bickel WK, Bigelow GE, Preston KL, Liebson IA (1989). Opioid drug discrimination in humans: Stability, specificity and relation to self-reported drug effect. J Pharmacol Exp Ther 251:1053-1063.
6. Bickel WK, Oliveto AH, Kamein JB, Higgins ST, Hughes JR (1993). A novel-response procedure enhances the specificity and sensitivity of a triazolam discrimination in humans. J Pharmacol Exp Ther 264:360-367.
7. Buccafusco JJ, Marshall DC, Turner RM (1984). A comparison of the inhibitory effects of clonidine and guanfacine on the behavioral and autonomic components of morphine withdrawal in the rat. Life Sci 35:1401-1408.
8. Dwoskin LP, Neal BS, Sparber SB (1983). Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats. Eur J Pharmacol 90:269-273.
9. El-Kadi AOS, Sharif SI (1997). The influence of chronic treatment with clonidine, yohimbine and idazoxan on morphine withdrawal. Psychopharmacology 132:67-73.
10. Gellert VF, Holtzman SG (1979). Discriminative stimulus effects of naltrexone in the morphine-dependent rat. J Pharmacol Exp Ther 211:596-605.
11. Gold MS, Redmond DE Jr, Kleber HD (1978). Clonidine blocks acute opiate withdrawal symptoms. Lancet 2:599-602.
12. Gomaa AA, Moustafa SA, Farghali AA (1989). Adenosine triphosphate blocks opiate withdrawal symptoms in rats and mice. Pharmacol Toxicol 64:111-115.
13. Gossop M (1988). Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend 21:253-259.
14. Grasing K, Sturgill MG, Rosen RC, Trout JR, Thomas TJ, Kulkarni GD, et al. (1996). Effects of yohimbine on autonomic measures are determined by individual values for area under the concentration-time curve. J Clin Pharmacol 36:814-822.
15. Guitart X, Nestler EJ (1989). Identification of morphine and cyclic AMP-regulated phosphoproteins (MARPPS) in the locus coeruleus and other regions of the rat brain: Regulation by acute and chronic morphine. J Neurosci 9:4371-4387.
16. Hameedi FA, Woods SW, Rosen MI, Pearsall HR, Kosten TR (1997). Dose dependent effects of yohimbine on methadone maintained patients. Am J Drug Alcohol Abuse 23:327-333.
17. Hartmann F, Poirier MF, Bourdel MC, Loo H, Lecomte JM, Schwartz JC (1991). Comparison of acetorphan with clonidine for opiate withdrawal symptoms. Am J Psychiatry 148:627-629.
18. Holtzman SG (1985). Discriminative stimulus effects of morphine withdrawal in the dependent rat: Suppression by opiate and nonopiate drugs. J Pharmacol Exp Ther 233:80-86.
19. Iglesias V, Alguacil LF, Alamo C, Cuenca E (1992). Effects of yohimbine on morphine analgesia and physical dependence in the rat. Eur J Pharmacol 211:35-38.
20. Jasinski DR (1977.) Assessment of the abuse potential of morphine-like drugs (methods used in man). In: Martin WR (editor): Drug Addiction I. New York: Springer-Verlag; pp. 197-258.
21. Jasinski DR, Johnson RE, Kocher TR (1985). Clonidine in morphine withdrawal: Differential effects on signs and symptoms. Arch Gen Psychiatry 42:1063-1066.
22. Kamien JB, Bickel WK, Oliveto AH, Smith BJ, Higgins ST, Hughes JR (1994). Triazolam discrimination by humans under a novel-response procedure: Effects of buspirone and lorazepam. Behav Pharmacol 5:315-325.
23. Katz JL (1986). Effects of clonidine and morphine on opiate withdrawal in rhesus monkeys. Psychopharmacology 88:392-397.
24. Kleber HD, Riordan CE, Rounsaville BJ, Kosten TR, Charney DS, Gaspari J, et al. (1985). Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry 42:391-394.
25. Kogan JH, Nestler EJ, Aghajanian GK (1992). Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur J Pharmacol 211:47-53.
26. Koob GF, Maldonado R, Stinus L (1992). Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
27. Kosten TA (1994). Clonidine attenuates conditioned place aversion to naloxone-precipitated opioid withdrawal in rats. Eur J Pharmacol 254:59-63.
28. Kosten TR, Rounsaville BJ, Kleber HD (1985). Comparison of clinical ratings to self-reports of withdrawal during clonidine detoxification of opiate addicts. Am J Drug Alcohol Abuse 11:1-10.
29. Lannon RA, Batki S, Jones RT (1986). Yohimbine produces opioid withdrawal-like reaction in addicts. NIDA Res Monogr 75:655.
30. Martin WR, Sloan JW, Sapiro JD, Jasinski DR (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 12:245-258.
31. Moreau D (editor) (1996.) Nursing Drug Handbook. Springhill, PA: Springhouse Corporation; pp. 249-251.
32. Nestler EJ (1992). Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450.
33. Oliveto AH, Bickel WK, Kamien J, Hughes JR, Higgins ST (1994). Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology 114:417-423.
34. Oliveto AH, Rosen M, Kosten TA, Hameedi F, Woods S, Kosten TR (1998). Naloxone discrimination in opioid-dependent humans under a novel-response discrimination procedure. Exp Clin Psychopharmacol 6:169-178.
35. Oliveto A, Sevarino K, McCance-Katz E, Feingold A (2002). Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure. Pharmacol Biochem Behav 71:85-96.
36. Preston KL, Bigelow GE, Bickel WK, Liebson IA (1987). Three-choice drug discrimination in opioid-dependent humans: Hydromorphone, naloxone and saline. J Pharmacol Exp Ther 243:1002-1009.
37. Preston KL, Bigelow GE, Bickel WK, Liebson IA (1989). Drug discrimination in human post-addicts: Agonist-antagonist opioids. J Pharmacol Exp Ther 250:184-196.
38. Preston KL, Bigelow GE, Liebson IA (1990). Discrimination of butorphanol and nalbuphine in opioid-dependent subjects. Pharmacol Biochem Behav 37:511-522.
39. Rasmussen K, Beitner-Johnson D, Krystal JH, Aghajanian GK, Nestler EJ (1990). Opiate withdrawal and the rat locus coeruleus: Behavioral electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
40. Redmond DE, Krystal JH (1984). Multiple mechanisms of withdrawal from opioid drugs. Ann Rev Neurosci 7:443-478.
41. Rosen MI, McMahon TJ, Hameedi FA, Pearsall HR, Woods SW, Kreek MJ, Kosten TR (1996). Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. J Pharmacol Exp Ther 276:1128-1135.
42. Rosen MI, Kosten TR, Kreek MJ (1999). The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers. Biol Psychiatry 45:1636-1645.
43. Rounsaville BJ, Kosten TR, Kleber HD (1985). Success and failure at outpatient opioid detoxification: Evaluating the process of clonidine and methadone-assisted withdrawal. J Nerv Mental Dis 173:103-110.
44. Smith BJ, Bickel WK (1999). The novel-response procedure in humans. Pharmacol Biochem Behav 64:245-250.
45. Sparber SB, Meyer DR (1978). Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats. Pharmacol Biochem Behav 9:319-325.
46. Stine SM, Krystal J, Southwick S, Morgan A, Grillon C, Charney D (1996). Yohimbine induces withdrawal and anxiety symptoms and increased acoustic startle response in methadone-maintained patients. College on the Problems of Drug Dependence, 57th Annual Meeting, June 1995. NIDA Monograph 162:118.
47. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond DE (1988). Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96:121-134.
48. Taylor JR, Lewis VO, Elsworth JD, Pivirotto RH, Roth RH, Redmond DE Jr (1991). Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats. Psychopharmacology 103:407-414.
49. Tseng LF, Loh HH, Wei ET (1975). Effects of clonidine on morphine withdrawal signs in the rat. Eur J Pharmacol 30:93-99.
50. Vaupel DB, Kimes AS, London ED (1995). Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology 118:361-368.
51. Winer BJ (1962.) Statistical Principals in Experimental Design. New York: McGraw-Hill.
52. Zweben JE, Payte JT (1990). Methadone maintenance in the treatment of opioid dependence: A current perspective. West J Med 152:588-599.